A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
According to the Taiwanese government's official annual report listing the top 10 causes of death, cancer was the leading cause of death in Taiwan in 2013, with hepatocellular carcinoma ranking second among those cancer deaths. Transarterial chemoembolization has been shown to be widely used in...
Main Authors: | Wei-Chen Lin, Tsang-En Wang, Horng-Yang Wang, Shou-Chuan Shih |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-12-01
|
Series: | Journal of Cancer Research and Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S231130061630091X |
Similar Items
-
Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Sun Joon Moon, et al.
Published: (2024-03-01) -
Evaluation of patients undergoing Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma with respect to tumor size, site and number of lesions
by: Amjad Sattar, et al.
Published: (2013-12-01) -
Transarterial chemoembolization and early arterial complications after liver transplantation for hepatocellular carcinoma
by: V. V. Borovik, et al.
Published: (2022-09-01) -
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization
by: Zhang B, et al.
Published: (2024-03-01) -
Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma Patient
by: Hsaing-Hung Lin, et al.
Published: (2014-09-01)